{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:33:42Z","timestamp":1787960022046,"version":"build-2784847793"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To assess differences in estimated cardiovascular disease (CVD) risk among rheumatoid arthritis (RA) patients from different world regions and to evaluate the management and goal attainment of lipids and blood pressure (BP).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>The survey of CVD risk factors in patients with RA was conducted in 14\u00a0503 patients from 19 countries during 2014\u201319. The treatment goal for BP was &amp;lt;140\/90\u00a0mmHg.\u00a0CVD risk prediction and lipid goals were according to the 2016 European guidelines. Overall, 21% had a very high estimated risk of CVD, ranging from 5% in Mexico, 15% in Asia, 19% in Northern Europe, to 31% in Central and Eastern Europe and 30% in North America. Of the 52% with indication for lipid-lowering treatment (LLT), 44% were using LLT. The lipid goal attainment was 45% and 18% in the high and very high risk groups, respectively. Use of statins in monotherapy was 24%, while 1% used statins in combination with other LLT. Sixty-two per cent had hypertension and approximately half of these patients were at BP goal. The majority of the patients used antihypertensive treatment in monotherapy (24%), while 10% and 5% as a two- or three-drug combination.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We revealed considerable geographical differences in estimated CVD risk and preventive treatment. Low goal attainment for LLT was observed, and only half the patients obtained BP goal. Despite a high focus on the increased CVD risk in RA patients over the last decade, there is still substantial potential for improvement in CVD preventive measures.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvab052","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T11:32:15Z","timestamp":1625484735000},"page":"539-548","source":"Crossref","is-referenced-by-count":22,"title":["An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-3241","authenticated-orcid":false,"given":"Silvia","family":"Rollefstad","sequence":"first","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital , Diakonveien 12, 0370 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik","family":"Ikdahl","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital , Diakonveien 12, 0370 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grunde","family":"Wibetoe","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital , Diakonveien 12, 0370 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Sexton","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital , Diakonveien 12, 0370 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S","family":"Crowson","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic , Rochester, MN, USA"},{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"van Riel","sequence":"additional","affiliation":[{"name":"Bernhoven Hospital , Uden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D","family":"Kitas","sequence":"additional","affiliation":[{"name":"Dudley Group NHS Foundation Trust , Dudley, West Midlands, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0979-4674","authenticated-orcid":false,"given":"Ian","family":"Graham","sequence":"additional","affiliation":[{"name":"Trinity College Dublin , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbritt Rantap\u00e4\u00e4","family":"Dahlqvist","sequence":"additional","affiliation":[{"name":"Swedish Rheumatoid Arthritis Registry , Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Karpouzas","sequence":"additional","affiliation":[{"name":"The Lundquist Institute, Harbor-UCLA Medical Center , Torrance, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Myasoedova","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Gonzalez-Gay","sequence":"additional","affiliation":[{"name":"Hospital Universitario Marqu\u00e9s de Valdecilla , Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, First Department of Propaedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Tektonidou","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, First Department of Propaedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyro","family":"Lazarini","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, 2nd Department of Medicine and Laboratory, Hippokration General Hospital, National and Kapodistrian University of Athens , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Vassilopoulos","sequence":"additional","affiliation":[{"name":"Joint Rheumatology Program, 2nd Department of Medicine and Laboratory, Hippokration General Hospital, National and Kapodistrian University of Athens , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindee","family":"Kuriya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Hitchon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Manitoba , Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Simona","family":"Stoenoiu","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Cliniques Universitaires Saint Luc, Institut de recherche exp\u00e9rimentale et clinique, Universit\u00e9 catholique de Louvain, Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Cliniques Universitaires Saint Luc, Institut de recherche exp\u00e9rimentale et clinique, Universit\u00e9 catholique de Louvain, Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pascual-Ramos","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , M\u00e9xico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionicio Angel","family":"Galarza-Delgado","sequence":"additional","affiliation":[{"name":"Hospital Universitario \u2018Dr Jos\u00e9 E. Gonz\u00e1lez\u2019, UANL , Monterrey, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompilio","family":"Faggiano","sequence":"additional","affiliation":[{"name":"Spedali Civili and University of Brescia , Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga Prasanna","family":"Misra","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) , Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Borg","sequence":"additional","affiliation":[{"name":"Mater Dei , Msida, Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People's Hospital , Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkin M","family":"Mirrakhimov","sequence":"additional","affiliation":[{"name":"Kyrgyz State Medical Academy , Bishkek, Kyrgyz Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Gheta","sequence":"additional","affiliation":[{"name":"Tallagh University Hospital , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Myasoedova","sequence":"additional","affiliation":[{"name":"Ivanovo State Medical Academy , Ivanovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Krougly","sequence":"additional","affiliation":[{"name":"Center of Cardiology of Russian Ministry of Healthcare , Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Popkova","sequence":"additional","affiliation":[{"name":"V.A.\u00a0Nasonova\u00a0Research Institute of Rheumatology , Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Tuchy\u0148ov\u00e1","sequence":"additional","affiliation":[{"name":"National Institute of Rheumatic Diseases , 92101 Pie\u0161\u0165any, Slovensko, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tomcik","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Department of Rheumatology, First Faculty of Medicine, Charles University , Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Vrablik","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Department of Endocrinology and Metabolism, First Medical Faculty, Charles University and General Faculty Hospital , Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Lastuvka","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Department of Endocrinology and Metabolism, First Medical Faculty, Charles University and General Faculty Hospital , Prague, Czech Republic"},{"name":"First Medical Faculty, Charles University , Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Hor\u00e1k","sequence":"additional","affiliation":[{"name":"Iii Interna klinika fn Olomouc , Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Medkov\u00e1","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, 2nd Department of Internal Medicine\u2014Gastroenterology, Charles University, Faculty of Medicine in Hradec Kr\u00e1lov\u00e9 and University Hospital Hradec Kr\u00e1lov\u00e9, Hradec Kr\u00e1lov\u00e9, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Grete","family":"Semb","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma Clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital , Diakonveien 12, 0370 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"2022092404475980700_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41584-020-0428-y","article-title":"Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis","volume":"16","author":"Semb","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2022092404475980700_bib2","first-page":"813","article-title":"Trend in and predictors for cardiovascular mortality in patients with rheumatoid arthritis over a period of 15 years: a prospective cohort study","volume":"34","author":"van den Hoek","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2022092404475980700_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/acr.22296","article-title":"Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register","volume":"66","author":"Humphreys","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2022092404475980700_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/annrheumdis-2017-212131","article-title":"Mortality following new-onset rheumatoid arthritis: has modern rheumatology had an impact?","volume":"77","author":"Holmqvist","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022092404475980700_bib5","first-page":"391","article-title":"No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000\u20132008","volume":"33","author":"Kerola","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2022092404475980700_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3899\/jrheum.161154","article-title":"Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (RA) in recent years: dawn of a new era in cardiovascular disease in RA?","volume":"44","author":"Myasoedova","year":"2017","journal-title":"J Rheumatol"},{"key":"2022092404475980700_bib7","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41598-020-60621-2","article-title":"Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population\u2014the Nord-Trondelag Health Study","volume":"10","author":"Houge","year":"2020","journal-title":"Sci Rep"},{"key":"2022092404475980700_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/2047487312467870","article-title":"SURF\u2014SUrvey of Risk Factor management: first report of an international audit","volume":"21","author":"Cooney","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"2022092404475980700_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.114.010001","article-title":"Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III)","volume":"130","author":"Doran","year":"2014","journal-title":"Circulation"},{"key":"2022092404475980700_bib10","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2022092404475980700_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022092404475980700_bib12","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/2047487316653709","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"23","author":"Piepoli","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2022092404475980700_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/2047487314547652","article-title":"Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry","volume":"22","author":"Ferrari","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2022092404475980700_bib14","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.atherosclerosissup.2021.01.004","article-title":"The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study","volume":"42","author":"Jozwiak","year":"2020","journal-title":"Atheroscler Suppl"},{"key":"2022092404475980700_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022092404475980700_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","article-title":"Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"110","author":"Crowson","year":"2012","journal-title":"Am J Cardiol"},{"key":"2022092404475980700_bib17","doi-asserted-by":"crossref","first-page":"e0174656","DOI":"10.1371\/journal.pone.0174656","article-title":"Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis","volume":"12","author":"Crowson","year":"2017","journal-title":"PLoS One"},{"key":"2022092404475980700_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3899\/jrheum.171008","article-title":"Performance of the expanded cardiovascular risk prediction score for rheumatoid arthritis is not superior to the ACC\/AHA risk calculator","volume":"46","author":"Wahlin","year":"2019","journal-title":"J Rheumatol"},{"key":"2022092404475980700_bib19","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"2022092404475980700_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"2022092404475980700_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/art.40892","article-title":"Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA): a multicenter, randomized, placebo controlled trial","volume":"71","author":"Kitas","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2022092404475980700_bib22","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/art.34524","article-title":"Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease","volume":"64","author":"Semb","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022092404475980700_bib23","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"2022092404475980700_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2296-14-150","article-title":"Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study","volume":"14","author":"Monk","year":"2013","journal-title":"BMC Fam Pract"},{"key":"2022092404475980700_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2015.49807","article-title":"Statin intolerance\u2014an attempt at a unified definition. Position paper from an International Lipid Expert Panel","volume":"11","author":"Banach","year":"2015","journal-title":"Arch Med Sci"},{"key":"2022092404475980700_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022092404475980700_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/kev427","article-title":"Cardiovascular risk factor management in patients with RA compared to matched non-RA patients","volume":"55","author":"Alemao","year":"2016","journal-title":"Rheumatology"},{"key":"2022092404475980700_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/acr.22740","article-title":"Traditional cardiovascular disease risk factor management in rheumatoid arthritis compared to matched nonrheumatoid arthritis in a US managed care setting","volume":"68","author":"An","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2022092404475980700_bib29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3899\/jrheum.121302","article-title":"Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study","volume":"40","author":"Akkara Veetil","year":"2013","journal-title":"J Rheumatol"},{"key":"2022092404475980700_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/ard.2009.115717","article-title":"Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?","volume":"69","author":"Toms","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022092404475980700_bib31","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/annrheumdis-2011-200806","article-title":"Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study","volume":"71","author":"Lindhardsen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022092404475980700_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"key":"2022092404475980700_bib33","first-page":"zwaa047","article-title":"EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","author":"Ray","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2022092404475980700_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2022092404475980700_bib35","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/annrheumdis-2012-202789","article-title":"Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic","volume":"72","author":"Rollefstad","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022092404475980700_bib36","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2013-204636","article-title":"Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention","volume":"74","author":"Rollefstad","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022092404475980700_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/acr.22302","article-title":"Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care","volume":"66","author":"Bartels","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2022092404475980700_bib38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","article-title":"Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatology"},{"key":"2022092404475980700_bib39","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/HJH.0b013e328348efa7","article-title":"Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey","volume":"29","author":"Prugger","year":"2011","journal-title":"J Hypertens"},{"key":"2022092404475980700_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvab052\/39350690\/pvab052.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/8\/6\/539\/45986478\/pvab052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/8\/6\/539\/45986478\/pvab052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T05:25:34Z","timestamp":1663997134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/8\/6\/539\/6316776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,7,7]]},"published-print":{"date-parts":[[2022,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvab052","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2021,7,7]]}}}